USDA-Approved THC And CBD-Free Hemp Strain Seeks To Curb ~25% Crop Loss Due To Non-Compliance

Zinger Key Points
  • USDA approves innovative hemp strain developed by University of Wisconsin, targeting 25% crop loss due to non-compliant THC levels.
  • Genetic alteration ensures THC-free hemp, optimizing yield and meeting 2018 Farm Bill regulations.
  • Approval marks pivotal step towards industry stability amid regulatory uncertainties and bipartisan calls for compliance.

The U.S. Department of Agriculture (USDA) has granted regulatory approval for a genetically modified hemp strain, “Badger G,” developed by the Wisconsin Crop Innovation Center at the University of Wisconsin-Madison. This novel hemp strain, distinguished by its absence of THC and CBD, was designed to ensure compliance with federal thresholds and offer agronomic advantages to farmers.

Innovating Gene Editing At The Forefront

The Badger G distinguishes itself by producing higher levels of the cannabinoid CBG, without the psychoactive THC. Employing CRISPR/Cas9 gene-editing technology, the scientists successfully nullified the CBDAS gene responsible for THC and CBD synthesis. 

This genetic alteration ensures compliance with the 2018 Farm Bill, which requires a 0.3% THC threshold. In this way, it mitigates the risk of crop elimination due to excessive THC levels, a problem affecting approximately 25% of the US hemp crop, according to the regulatory approval request submitted by the University of Wisconsin.

The discussion on the impact of genetically modified hemp strains and the necessity for robust regulatory frameworks will take center stage at the upcoming Benzinga Cannabis Capital Conference in Florida on April 16-17, 2024. 

Implications For The Hemp Industry And Beyond

The USDA’s approval, as per its Animal and Plant Health Inspection Service (APHIS) response, underscores “Badger G’s” safety and its non-invasive nature to the agricultural ecosystem. This marks the APHIS' second approval of a genetically modified hemp variety, following the green light given to a THC and CBC-reduced strain by Growing Together Research Inc. in October.

This move not only amplifies the genetic diversity within the hemp industry but aligns with federal efforts to bolster hemp research, as evidenced by the recent $10 million investment in hemp studies and the establishment of a public-private hemp consortium.

Furthermore, the approval arrives amid industry efforts to address regulatory uncertainties, with stakeholders advocating for a 1% THC compliance threshold in the new Farm Bill. This objective, one of seven outlined by the hemp industry, seeks to provide clarity and support for hemp businesses while ensuring consumer safety and market stability.

Innovation Amid Regulatory Hurdles

In light of the growing evidence about the failures in the regulation of hemp-derived products and the recent bipartisan push to regulate intoxicating hemp products, the USDA’s approval of the genetically modified hemp strain “Badger G” emerges as promising. It not only aims to ensure regulatory compliance but also to unlock new potentials in hemp cultivation and product development.

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world. Get your tickets now on bzcannabis.com – Prices will increase very soon!

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.